<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" nameag="viewport"/>
<title>Pharmacology Dvt Revision Test</title>
<script src="https://cdn.tailwindcss.com"></script>
<script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
<script src="https://cdn.jsdelivr.net/npm/canvas-confetti@1.6.0/dist/confetti.browser.min.js"></script>
<style>
        /* Custom styles for enhanced aesthetics and responsiveness */
        .option-btn {
            transition: all 0.3s ease;
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
        }
        .option-btn:hover, .option-btn:active {
            transform: scale(1.02);
            box-shadow: 0 4px 8px rgba(0, 0, 0, 0.2);
        }
        .option-btn.selected {
            background-color: #3b82f6;
            color: white;
        }
        .marked {
            background-color: #fef08a;
        }
        .progress-bar {
            transition: width 0.5s ease-in-out;
            background: linear-gradient(to right, #3b82f6, #22c55e);
            box-shadow: 0 2px 4px rgba(0, 0, 0, 0.2);
            animation: pulse 2s infinite;
        }
        @keyframes pulse {
            0% { opacity: 1; }
            50% { opacity: 0.8; }
            100% { opacity: 1; }
        }
        .question-nav-btn, .result-nav-btn-grid {
            width: 40px;
            height: 40px;
            display: flex;
            align-items: center;
            justify-content: center;
            border-radius: 8px;
            font-size: 16px;
            touch-action: manipulation;
            transition: all 0.2s ease;
        }
        .question-nav-btn:hover, .question-nav-btn:active, .result-nav-btn-grid:hover, .result-nav-btn-grid:active {
            transform: scale(1.05);
        }
        .answered {
            background-color: #22c55e;
            color: white;
        }
        .unanswered {
            background-color: #e5e7eb;
        }
        .marked-nav {
            border: 2px solid #fef08a;
        }
        .video-container, .audio-container {
            display: none;
            position: relative;
        }
        .video-container.active, .audio-container.active {
            display: block;
            animation: fadeIn 0.5s ease-in;
        }
        @keyframes fadeIn {
            from { opacity: 0; }
            to { opacity: 1; }
        }
        .section-transition {
            transition: opacity 0.3s ease;
        }
        .section-transition.hidden {
            opacity: 0;
            pointer-events: none;
        }
        .result-nav {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-top: 1rem;
        }
        .result-nav-btn {
            background-color: #4b5563;
            color: white;
            padding: 0.5rem 1rem;
            border-radius: 8px;
            transition: all 0.2s ease;
        }
        .result-nav-btn:hover, .result-nav-btn:active {
            background-color: #374151;
            transform: scale(1.05);
        }
        .result-nav-btn:disabled {
            background-color: #d1d5db;
            cursor: not-allowed;
        }
        .error-message {
            color: #dc2626;
            font-weight: bold;
            margin-top: 1rem;
        }
        /* Mobile-specific adjustments */
        @media (max-width: 640px) {
            .question-nav-btn, .result-nav-btn-grid {
                width: 38px;
                height: 38px;
                font-size: 14px;
            }
            .nav-panel, .results-nav-panel {
                width: 100%;
                max-width: 100%;
                overscroll-behavior: contain;
            }
            .option-btn {
                padding: 12px;
                font-size: 14px;
            }
            .header-text {
                font-size: 1.5rem;
            }
            .subheader-text {
                font-size: 0.875rem;
            }
            .button-group, .result-nav {
                flex-direction: column;
                gap: 0.5rem;
            }
            .result-nav-btn {
                width: 100%;
                text-align: center;
            }
        }
        /* Dark mode styles */
        .dark .bg-gray-100 {
            background-color: #1f2937;
        }
        .dark .bg-white {
            background-color: #374151;
        }
        .dark .text-gray-700 {
            color: #d1d5db;
        }
        .dark .text-gray-800 {
            color: #e5e7eb;
        }
        .dark .bg-gray-200 {
            background-color: #4b5563;
        }
        .dark .border {
            border-color: #4b5563;
        }
        .dark .bg-blue-500 {
            background-color: #2563eb;
        }
        .dark .hover\:bg-blue-600:hover {
            background-color: #1d4ed8;
        }
        .dark .bg-yellow-300 {
            background-color: #b45309;
            color: white;
        }
        .dark .hover\:bg-yellow-400:hover {
            background-color: #92400e;
        }
        .dark .bg-green-500 {
            background-color: #15803d;
        }
        .dark .hover\:bg-green-600:hover {
            background-color: #166534;
        }
        .dark .bg-gray-500 {
            background-color: #4b5563;
        }
        .dark .hover\:bg-gray-600:hover {
            background-color: #374151;
        }
        .dark .result-nav-btn, .dark .result-nav-btn-grid {
            background-color: #2563eb;
        }
        .dark .result-nav-btn:hover, .dark .result-nav-btn:active, .dark .result-nav-btn-grid:hover, .dark .result-nav-btn-grid:active {
            background-color: #1d4ed8;
        }
        .dark .result-nav-btn:disabled, .dark .result-nav-btn-grid:disabled {
            background-color: #4b5563;
        }
        .video-placeholder {
            width: 400px;
            height: 300px;
            background-color: #f0f0f0;
            display: flex;
            align-items: center;
            justify-content: center;
            cursor: pointer;
            margin-top: 10px;
            border-radius: 8px;
            border: 1px solid #ccc;
        }
        .play-icon {
            font-size: 40px;
            color: #007bff;
        }
        .video-loading {
            position: absolute;
            top: 50%;
            left: 50%;
            transform: translate(-50%, -50%);
            border: 4px solid #f3f3f3;
            border-top: 4px solid #3b82f6;
            border-radius: 50%;
            width: 40px;
            height: 40px;
            animation: spin 1s linear infinite;
        }
        @keyframes spin {
            0% { transform: translate(-50%, -50%) rotate(0deg); }
            100% { transform: translate(-50%, -50%) rotate(360deg); }
        }
    </style>

<script>
    // --- GEMINI AUTO-CAPTURE LISTENER ---
    // This function runs immediately after the quiz determines an answer is INCORRECT.
    function captureMistake(questionIndex, questionsData) {
        try {
            const item = questionsData[questionIndex];
            // Use the question text as a unique, stable identifier
            const uniqueId = 'srs_quiz_' + btoa(item.text.substring(0, 50)).replace(/=/g, ''); 

            // 1. Clean and simplify the explanation for storage
            let explanationText = item.explanation || item.correct_answer || "No explanation provided.";
            
            // Strip complex HTML (images, lists) and boilerplate text
            explanationText = explanationText.replace(/<img[^>]*>/g, "[IMAGE]").trim(); // Replace images with placeholder
            explanationText = explanationText.replace(/<p><strong>Ans\. [A-Z]\).*/i, "").trim(); // Remove the repeated Answer line
            explanationText = explanationText.replace(/<p><strong>Educational Objective:<\/strong>.*?<\/p>/gs, "").trim(); // Remove EO block
            explanationText = explanationText.replace(/@dams_new_robot/g, "");
            explanationText = explanationText.replace(/<\/?[^>]+(>|$)/g, " ").trim(); // Final strip of remaining tags

            // 2. Prepare card data
            const cardData = {
                text: item.text,
                answer: item.correct_answer,
                explanation: explanationText.substring(0, 500), // Keep explanations short
                nextReview: 0, // Due immediately
                reviews: 0,
                source: document.title.split('-')[0].trim() || 'Quiz'
            };

            // 3. Save to Local Storage (SRS Bank)
            localStorage.setItem(uniqueId, JSON.stringify(cardData));
            
            console.log(`ðŸ§  Captured Mistake #${questionIndex + 1} from ${document.title}`);

        } catch (e) {
            console.error("SRS Capture Failed:", e);
        }
    }
    // --- END GEMINI AUTO-CAPTURE LISTENER ---
</script>

</head>
<body class="bg-gray-100 font-sans transition-colors duration-300 min-h-screen overflow-y-auto">
<!-- Header Section -->
<header class="bg-blue-600 text-white p-4 shadow-lg">
<div class="container mx-auto">
<h1 class="text-2xl md:text-3xl font-bold header-text">Pharmacology Dvt Revision Test</h1>
<p class="mt-2 text-sm md:text-base subheader-text">
                25 Questions | 100 Total Marks | 35 min Duration | ~84.0 sec/question
            </p>
<button class="mt-2 bg-gray-200 text-gray-800 px-3 py-1 rounded-lg hover:bg-gray-300 transition dark:bg-gray-600 dark:text-white" id="theme-toggle">
                Toggle Dark Mode
            </button>
</div>
</header>
<!-- Instructions Section -->
<section class="container mx-auto p-4 md:p-6 section-transition" id="instructions">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-xl font-semibold mb-4">Instructions</h2>
<ul class="list-disc list-inside space-y-2 text-gray-700">
<li>This test contains 25 multiple choice questions.</li>
<li>Each question has only one correct answer.</li>
<li>You will have 35 minutes to complete the test.</li>
<li>Click or tap on an option to select your answer.</li>
<li>Use the "Mark for Review" button to revisit questions.</li>
<li>Navigate using Previous/Next buttons or the Questions Navigation panel.</li>
<li>Click "Submit" to finish and view results.</li>
<li>The test will auto-submit when time runs out.</li>
</ul>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="start-test">Start Test</button>


</div>
<div class="error-message hidden" id="error-message"></div>
</div>
</section>
<!-- Quiz Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="quiz">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<!-- Progress Bar -->
<div class="w-full bg-gray-200 rounded-full h-3 mb-4">
<div class="progress-bar h-3 rounded-full" id="progress-bar" style="width: 0%"></div>
</div>
<!-- Question Header -->
<div class="flex flex-col md:flex-row justify-between items-center mb-4">
<h2 class="text-lg font-semibold" id="question-number">Question <span>1</span> of 25</h2>
<p class="text-lg font-semibold mt-2 md:mt-0" id="timer">Time Remaining: <span>00:00</span></p>
</div>
<!-- Question Content -->
<div class="mb-6" id="question-content">
<p class="text-gray-800 mb-4" id="question-text"></p>
<div class="flex flex-wrap gap-4 mb-4" id="question-images"></div>
<div class="space-y-3" id="options"></div>
</div>
<!-- Navigation Buttons -->
<div class="flex flex-col md:flex-row justify-between items-center gap-2 md:gap-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition w-full md:w-auto" disabled="" id="previous-btn">Previous</button>
<button class="bg-yellow-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-yellow-400 transition w-full md:w-auto" id="mark-review">Mark for Review</button>
<button class="bg-blue-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="next-btn">Next</button>
<button class="bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full md:w-auto" id="nav-toggle">Questions Navigation</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-blue-600 transition w-full md:w-auto" id="submit-test">Submit Test</button>
</div>
</div>
</section>
<!-- Results Section -->
<section class="container mx-auto p-4 md:p-6 hidden section-transition" id="results">
<div class="bg-white rounded-lg shadow-md p-5 md:p-8 md:p-5 md:p-8 min-h-screen md:min-h-0 md:rounded-lg md:shadow-md rounded-none shadow-none flex flex-col justify-between">
<h2 class="text-2xl font-semibold mb-4">Pharmacology Dvt Revision Test - Results</h2>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 mb-6">
<p><strong>Correct:</strong> <span id="correct-count">0</span></p>
<p><strong>Wrong:</strong> <span id="wrong-count">0</span></p>
<p><strong>Unanswered:</strong> <span id="unanswered-count">0</span></p>
<p><strong>Marked for Review:</strong> <span id="marked-count">0</span></p>
</div>
<h3 class="text-lg font-semibold mb-4" id="result-question-number">Question <span>1</span> of 25</h3>
<div class="space-y-6" id="results-content"></div>
<div class="result-nav">
<button aria-label="Previous question result" class="result-nav-btn" disabled="" id="prev-result">Previous</button>
<button aria-label="Toggle results navigation panel" class="result-nav-btn" id="results-nav-toggle">Results Navigation</button>
<button aria-label="Next question result" class="result-nav-btn" id="next-result">Next</button>
</div>
<div class="mt-6 flex space-x-4 button-group md:flex-row flex-col">
<button class="bg-blue-500 text-white px-6 py-2 rounded-lg hover:bg-blue-600 transition" id="take-again">Take Again</button>
<button class="bg-gray-500 text-white px-6 py-2 rounded-lg hover:bg-gray-600 transition" id="review-test">Review Test</button>
</div>
</div>
</section>
<!-- Exit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="exit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Leave Test?</h2>
<p class="text-gray-700 mb-4">Your progress will be lost if you leave this page. Are you sure you want to exit?</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="continue-test">No, Continue</button>
<button class="bg-red-500 text-white px-4 py-2 rounded-lg hover:bg-red-600 transition" id="exit-test">Yes, Exit</button>
</div>
</div>
</div>
<!-- Submit Confirmation Modal -->
<div class="fixed inset-0 bg-black bg-opacity-50 flex items-center justify-center hidden" id="submit-modal">
<div class="bg-white rounded-lg p-6 max-w-sm w-full">
<h2 class="text-xl font-semibold mb-4">Confirm Submission</h2>
<p class="text-gray-700 mb-2">You have attempted <span id="attempted-count">0</span> of 25 questions.</p>
<p class="text-gray-700 mb-4"><span id="unattempted-count">0</span> questions are unattempted.</p>
<div class="flex justify-end space-x-4">
<button class="bg-gray-300 text-gray-700 px-4 py-2 rounded-lg hover:bg-gray-400 transition" id="cancel-submit">Cancel</button>
<button class="bg-green-500 text-white px-4 py-2 rounded-lg hover:bg-green-600 transition" id="confirm-submit">Submit Test</button>
</div>
</div>
</div>
<!-- Quiz Navigation Panel -->
<div class="fixed inset-y-0 right-0 nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="nav-panel">
<h2 class="text-lg font-semibold mb-4">Questions Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-nav">Close</button>
</div>
<!-- Results Navigation Panel -->
<div class="fixed inset-y-0 right-0 results-nav-panel bg-white shadow-lg p-4 hidden overflow-y-auto" id="results-nav-panel">
<h2 class="text-lg font-semibold mb-4">Results Navigation</h2>
<div class="mb-4">
<select class="w-full p-2 border rounded-lg text-gray-700" id="results-nav-filter">
<option value="all">All Questions</option>
<option value="answered">Answered</option>
<option value="unanswered">Unanswered</option>
<option value="marked">Marked for Review</option>
</select>
</div>
<div class="grid grid-cols-5 gap-2 md:gap-3" id="results-nav-grid"></div>
<button class="mt-4 bg-gray-500 text-white px-4 py-2 rounded-lg hover:bg-gray-600 transition w-full" id="close-results-nav">Close</button>
</div>
<!-- JavaScript Logic -->
<script>
        // Enable debug mode for detailed logging
        const DEBUG_MODE = true;

        // Log debug messages
        function debugLog(message) {
            if (DEBUG_MODE) {
                console.log(`[DEBUG] ${message}`);
            }
        }

        // Initialize questions with error handling
        let questions = [];
        let currentResultQuestion = 0; // State for current question in results
        try {
            debugLog("Attempting to parse questions_json");
            questions = [{"text": "A patient on cardiac medication, developed this complication (given in the ECG), For treating this problem, which one of the following is the suitable medication?", "options": [{"label": "A", "text": "Sotalol", "correct": false}, {"label": "B", "text": "Procainamide", "correct": false}, {"label": "C", "text": "Magnesium sulphate", "correct": true}, {"label": "D", "text": "Dronedarone", "correct": false}], "correct_answer": "C. Magnesium sulphate", "question_images": ["https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5103).png"], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ The immediate treatment for Torsades de Pointes, especially in a patient on cardiac medication, is intravenous Magnesium Sulfate. Magnesium acts as a calcium channel blocker and can stabilize the cardiac membrane, effectively suppressing TdP. Sotalol, Procainamide, and Dronedarone are antiarrhythmic drugs themselves and can cause or worsen TdP, making them unsuitable for treating this specific complication.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "All of the following drugs causes adverse effects of agranulocytosis except", "options": [{"label": "A", "text": "Carbimazole", "correct": false}, {"label": "B", "text": "Tocainide", "correct": false}, {"label": "C", "text": "Clozapine", "correct": false}, {"label": "D", "text": "Lithium", "correct": true}], "correct_answer": "D. Lithium", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Lithium is a mood stabilizer primarily used in the treatment of bipolar disorder. While lithium can cause a benign and reversible increase in white blood cell count (leukocytosis), it is not typically associated with agranulocytosis. Its side effect profile differs from the other drugs listed in this regard.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A patient with Alzheimer disease needs treatment for overactive bladder (OAB). Which drug is the best choice for this patient?", "options": [{"label": "A", "text": "Darifenacin", "correct": false}, {"label": "B", "text": "Solifenacin", "correct": false}, {"label": "C", "text": "Tolterodine", "correct": false}, {"label": "D", "text": "Trospium", "correct": true}], "correct_answer": "D. Trospium", "question_images": [], "explanation_images": [], "explanation": "<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Direct guanyl cyclase activator useful in primary pulmonary hypertension is", "options": [{"label": "A", "text": "Bosentan", "correct": false}, {"label": "B", "text": "Riociguat", "correct": true}, {"label": "C", "text": "Fasudil", "correct": false}, {"label": "D", "text": "Iloprost", "correct": false}], "correct_answer": "B. Riociguat", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Riociguat (option B) is a direct stimulator of soluble guanylate cyclase (sGC). Soluble guanylate cyclase is an enzyme in the nitric oxide (NO) signaling pathway. NO stimulates sGC, leading to increased production of cyclic guanosine monophosphate (cGMP), which promotes vasodilation and inhibits vascular smooth muscle proliferation. Riociguat directly activates sGC, independent of NO, and also sensitizes sGC to endogenous NO, thereby enhancing the NO-sGC-cGMP pathway. This action leads to relaxation of pulmonary vascular smooth muscle and is useful in treating pulmonary hypertension.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Apixaban action is reversed by", "options": [{"label": "A", "text": "Andexanet alpha", "correct": true}, {"label": "B", "text": "Idaracizumab", "correct": false}, {"label": "C", "text": "Avidin", "correct": false}, {"label": "D", "text": "Protamine sulfate", "correct": false}], "correct_answer": "A. Andexanet alpha", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Andexanet alfa (option A) is a recombinant modified human Factor Xa decoy protein. It acts as a specific reversal agent for Factor Xa inhibitors like apixaban (and rivaroxaban) by binding to them, thereby sequestering the anticoagulant and allowing endogenous Factor Xa to resume its role in coagulation.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which is the thiazide effective even in the presence of renal failure?", "options": [{"label": "A", "text": "Chlorthalidone", "correct": false}, {"label": "B", "text": "Metolazone", "correct": true}, {"label": "C", "text": "Hydrochlorothiazide", "correct": false}, {"label": "D", "text": "Chlorthiazude", "correct": false}], "correct_answer": "B. Metolazone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ However, among the thiazide-type diuretics, Metolazone (option B) is unique because it maintains its diuretic efficacy even in patients with moderate to severe renal impairment (low GFR). While it is structurally a quinazolinone derivative rather than a true thiazide, it is often grouped with thiazides due to its similar mechanism of action (inhibiting the Na+/Cl- cotransporter in the distal convoluted tubule) and clinical uses. Chlorthalidone, Hydrochlorothiazide, and Chlorothiazide are typical thiazide diuretics whose efficacy diminishes significantly in the presence of renal failure.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the following regarding adverse effects of cholesterol lowering agents", "options": [{"label": "A", "text": "1-C, 2-D, 3-B, 4-A", "correct": false}, {"label": "B", "text": "1-D, 2-D, 3-B, 4-A", "correct": false}, {"label": "C", "text": "1-D, 2-A, 3-B, 4-C", "correct": true}, {"label": "D", "text": "1-B, 2-A, 3-D, 4-C", "correct": false}], "correct_answer": "C. 1-D, 2-A, 3-B, 4-C", "question_images": ["https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5104).png"], "explanation_images": [], "explanation": "<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which option is most appropriate for a patient with newly diagnosed hyperthyroidism in the first trimester of pregnancy?", "options": [{"label": "A", "text": "Methimazole", "correct": false}, {"label": "B", "text": "Propylthiouracil (PTU)", "correct": true}, {"label": "C", "text": "Radioactive iodine", "correct": false}, {"label": "D", "text": "Surgical removal of thyroid", "correct": false}], "correct_answer": "B. Propylthiouracil (PTU)", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Propylthiouracil (PTU) (option B) is generally the preferred antithyroid drug during the first trimester of pregnancy. This is because methimazole, the other commonly used antithyroid drug, has been associated with a higher risk of teratogenic effects, specifically congenital malformations (e.g., aplasia cutis congenita, choanal atresia, esophageal atresia), if used during the first trimester. While PTU has its own risks (e.g., rare but severe hepatotoxicity), the risk of teratogenicity in the first trimester is considered lower than that of methimazole.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the following regarding antidiabetic drug and its site of", "options": [{"label": "A", "text": "1-B, 2-A, 3-D, 4-C", "correct": false}, {"label": "B", "text": "1-A, 2-C, 3-D, 4-A", "correct": false}, {"label": "C", "text": "1-D, 2-A, 3-B, 4-C", "correct": true}, {"label": "D", "text": "1-C, 2-A, 3-D, 4-B", "correct": false}], "correct_answer": "C. 1-D, 2-A, 3-B, 4-C", "question_images": ["https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5105).png"], "explanation_images": [], "explanation": "<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the following regarding anti diabetic drug and its adverse effects", "options": [{"label": "A", "text": "1-D, 2-C, 3-B, 4-A", "correct": false}, {"label": "B", "text": "1-B, 2-D, 3-B, 4-A", "correct": false}, {"label": "C", "text": "1-C, 2-D, 3-A, 4-B", "correct": false}, {"label": "D", "text": "1-B, 2-C, 3-D, 4-A", "correct": true}], "correct_answer": "D. 1-B, 2-C, 3-D, 4-A", "question_images": ["https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5106).png"], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ 1. Exenatide is a GLP-1 receptor agonist. While generally well-tolerated, GLP-1 agonists, including exenatide, have been associated with a risk of pancreatitis (B). Patients should be advised to seek medical attention if they develop symptoms of pancreatitis (severe abdominal pain).</li><li>â€¢ 2. Sitagliptin is a DPP-4 inhibitor. These drugs are generally well-tolerated, but common adverse effects include upper respiratory tract infections, such as nasopharyngitis (C).</li><li>â€¢ 3. Dapagliflozin is an SGLT2 inhibitor. By promoting glucose excretion in the urine, SGLT2 inhibitors can lead to increased risk of genitourinary infections (e.g., vulvovaginal candidiasis, urinary tract infections) and volume depletion, which can cause hypotension (D).</li><li>â€¢ 4. Pioglitazone is a thiazolidinedione (TZD). TZDs are known to increase the risk of fluid retention, which can lead to or worsen heart failure (A), especially in patients with pre-existing cardiac conditions. This is a significant contraindication and warning for this class of drugs.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Mr. X is a patient with type 2 diabetes currently being treated with insulin detemir. The physician determines that Mr. X needs additional insulin therapy for control of postprandial glucose. Which agent is most appropriate to add at this time?", "options": [{"label": "A", "text": "Insulin degludec", "correct": false}, {"label": "B", "text": "NPH insulin", "correct": false}, {"label": "C", "text": "Insulin lispro", "correct": true}, {"label": "D", "text": "NPH/regular 70/30 insulin", "correct": false}], "correct_answer": "C. Insulin lispro", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ To address postprandial glucose excursions, a rapid-acting insulin is typically added.</li><li>â€¢ Insulin lispro (C) is a rapid-acting insulin analog. It has a quick onset and a short duration of action, making it ideal for taking just before or with meals to cover the carbohydrate intake and control postprandial glucose levels.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Match the following regarding SERM and its indication", "options": [{"label": "A", "text": "1-D, 2-C, 3-B, 4-A", "correct": false}, {"label": "B", "text": "1-B, 2-A, 3-D, 4-C", "correct": true}, {"label": "C", "text": "1-C, 2-D, 3-A, 4-B", "correct": false}, {"label": "D", "text": "1-B, 2-C, 3-D, 4-A", "correct": false}], "correct_answer": "B. 1-B, 2-A, 3-D, 4-C", "question_images": ["https://d2enu63wt1sf3u.cloudfront.net/ckfinder/files/image(5107).png"], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ 1. Ospemifene is a SERM primarily indicated for the treatment of moderate to severe dyspareunia (B) (painful intercourse) due to vulvar and vaginal atrophy, a symptom of menopausal vaginal dryness. It acts as an estrogen agonist on vaginal tissue.</li><li>â€¢ 2. Ormiloxifene is a non-steroidal SERM used primarily as a non-hormonal, once-a-week oral contraceptive (A) in India. It works by interfering with implantation and having a mild estrogenic effect on the uterus.</li><li>â€¢ 3. Clomiphene (Clomiphene citrate) is a well-known SERM used in the treatment of infertility (D) in women. It works by blocking estrogen receptors in the hypothalamus, which leads to increased secretion of GnRH, and subsequently FSH and LH from the pituitary, stimulating ovulation.</li><li>â€¢ 4. Raloxifene is a SERM that acts as an estrogen agonist on bone and as an estrogen antagonist on breast and uterine tissue. Its primary indication is for the prevention and treatment of osteoporosis (C) in postmenopausal women, and it also reduces the risk of invasive breast cancer in certain high-risk postmenopausal women.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which one of the following monoclonal antibody useful in osteoporosis targeting against RANK-L?", "options": [{"label": "A", "text": "Burosumab", "correct": false}, {"label": "B", "text": "Blosozumab", "correct": false}, {"label": "C", "text": "Denosumab", "correct": true}, {"label": "D", "text": "Romosozumab", "correct": false}], "correct_answer": "C. Denosumab", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Denosumab (option C) is a fully human monoclonal antibody that specifically targets and binds to RANK-L. By doing so, it prevents RANK-L from binding to its receptor (RANK) on osteoclast precursors and mature osteoclasts. This inhibition leads to a decrease in osteoclast activity, thereby reducing bone resorption and increasing bone mineral density. It is widely used for the treatment of osteoporosis, particularly in postmenopausal women at high risk of fracture.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "A 55-year-old teacher was diagnosed with depression. After 6 weeks of therapy with fluoxetine, his symptoms improved, but he complains of sexual dysfunction. Which of the following drugs might be useful for management of depression in this patient?", "options": [{"label": "A", "text": "Sertraline", "correct": false}, {"label": "B", "text": "Citalopram", "correct": false}, {"label": "C", "text": "Mirtazapine", "correct": true}, {"label": "D", "text": "Lithium", "correct": false}], "correct_answer": "C. Mirtazapine", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Mirtazapine (C) is an atypical antidepressant that works by blocking Î±2â€‹-adrenergic autoreceptors, leading to increased release of norepinephrine and serotonin. It also blocks 5-HT2 and 5-HT3 serotonin receptors. Unlike SSRIs, mirtazapine is generally associated with a very low incidence of sexual dysfunction. This makes it a suitable alternative for patients experiencing this particular side effect with SSRIs.</li></ul>\n<p>@dams_new_robot</p>", "bot": "@dams_new_robot", "video": ""}, {"text": "Which one of the following drug useful for treating opioid poisoning as well as useful in prevention of relapse of opioid habit?", "options": [{"label": "A", "text": "Acamprostate", "correct": false}, {"label": "B", "text": "Naltrexone", "correct": true}, {"label": "C", "text": "Naloxone", "correct": false}, {"label": "D", "text": "Alvimopan", "correct": false}], "correct_answer": "B. Naltrexone", "question_images": [], "explanation_images": [], "explanation": "<p><strong>Explanation:</strong></p>\n<ul><li>â€¢ Naltrexone (B) fits this description. It is a long-acting opioid receptor antagonist.</li><li>â€¢ For opioid poisoning (overdose): While not typically the first-line for acute overdose due to its slower onset compared to naloxone, high doses of naltrexone can reverse opioid effects. However, its primary role in acute overdose is limited because its duration of action is longer than most short-acting opioids, which can lead to recurrent respiratory depression if not properly managed.</li><li>â€¢ For prevention of relapse: Naltrexone is very effective in preventing relapse for both opioid use disorder and alcohol use disorder. It blocks the euphoric and reinforcing effects of opioids, reducing cravings and preventing the \"high\" if opioids are used. It